Efficacy and safety of canagliflozin in subjects with type 2 diabetes: systematic review and meta-analysis Xu-Ping YangDan LaiYi-Lan Huang Review Article 16 August 2014 Pages: 1149 - 1158
Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects Martin Wehling Review Article 28 August 2014 Pages: 1159 - 1172
Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir Ivy SongJulie BorlandStephen C. Piscitelli Clinical Trial Open access 23 August 2014 Pages: 1173 - 1179
Impact of prior chronic statin therapy and high-intensity statin therapy at discharge on circulating endothelial progenitor cell levels in patients with acute myocardial infarction: a prospective observational study Natália AntónioRosa FernandesCarlos Fontes Ribeiro Pharmacodynamics 22 July 2014 Pages: 1181 - 1193
Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache Sarah CargninMichele VianaSalvatore Terrazzino Pharmacogenetics 07 August 2014 Pages: 1195 - 1202
Impact of cytochrome P450 inducers with or without inhibitors on the serum clobazam level in patients with antiepileptic polypharmacy Yoshiaki YamamotoYukitoshi TakahashiYoshiyuki Kagawa Pharmacokinetics and Disposition 22 July 2014 Pages: 1203 - 1210
Population pharmacogenetic pharmacokinetic modeling for flip-flop phenomenon of enteric-coated mycophenolate sodium in kidney transplant recipients Nayoung HanHwi-yeol YunJung Mi Oh Pharmacokinetics and Disposition 28 August 2014 Pages: 1211 - 1219
GFR may not accurately predict aspects of proximal tubule drug handling T. L. PuttStephen B. DuffullR. J. Walker Pharmacokinetics and Disposition 20 August 2014 Pages: 1221 - 1226
Ascertainment of acute liver injury in two European primary care databases A. RuigómezR. BrauerO. Klungel Pharmacoepidemiology and Prescription 29 July 2014 Pages: 1227 - 1235
Consequences of dextropropoxyphene market withdrawal in elderly patients with chronic pain Laurent BecquemontTiba DelespierrePhilippe Bertin Pharmacoepidemiology and Prescription 29 July 2014 Pages: 1237 - 1242
Pilot study to assess the influence of an enhanced medication plan on patient knowledge at hospital discharge Alexander Francesco Josef SendMichael SchwabHanna Marita Seidling Pharmacoepidemiology and Prescription 30 July 2014 Pages: 1243 - 1250
Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study Jolyce BourgeoisMonique M. ElseviersRobert H. Vander Stichele Pharmacoepidemiology and Prescription 08 August 2014 Pages: 1251 - 1260
Effects of “Fit fOR The Aged” (FORTA) on pharmacotherapy and clinical endpoints—a pilot randomized controlled study Carina MichalekMartin WehlingHelmut Frohnhofen Pharmacoepidemiology and Prescription 17 August 2014 Pages: 1261 - 1267
Treatment-related mortality with aflibercept in cancer patients Josep TaberneroSimon HitierEric Van Cutsem Letter to the Editors Open access 25 July 2014 Pages: 1269 - 1270
Strategy to address innovative off-label medication use in China: grading management Hanbin WuGao Wu Letter to the Editors Open access 17 August 2014 Pages: 1271 - 1273
Measurement of statin exposure in the absence of information on prescribed doses Tomi RomppainenMaria RikalaRisto Huupponen Letter to the Editors 22 August 2014 Pages: 1275 - 1276